News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
152 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (21243)
Month
January (3339)
February (3294)
March (4068)
April (3458)
May (4782)
June (3455)
July (2690)
August (3589)
September (3334)
October (3977)
November (4082)
December (2500)
Day
1 (2)
2 (5)
3 (51)
4 (11)
5 (136)
6 (140)
7 (50)
9 (2)
10 (140)
11 (193)
12 (119)
13 (155)
14 (53)
15 (2)
16 (5)
17 (153)
18 (162)
19 (149)
20 (175)
21 (74)
23 (5)
24 (163)
25 (169)
26 (152)
27 (186)
28 (69)
29 (4)
30 (4)
31 (161)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
9
10
11
12
13
14
15
16
17
18
19
20
21
23
24
25
26
27
28
29
30
31
Business
Nephros Schedules Second Quarter 2023 Financial Results Conference Call
Nephros, Inc. today announced that it will file its second-quarter financial results on Wednesday, August 9, 2023 after market close and will host a conference call that same day at 4:30pm ET.
July 26, 2023
·
1 min read
Business
Accuray to Report Fiscal Year-End 2023 Financial Results on August 9, 2023
Accuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter and fiscal year 2023, ended June 30, 2023, during a conference call hosted by company management at 1:30 p.m. PT / 4:30 p.m. ET on August 9, 2023.
July 26, 2023
·
1 min read
Genetown
Inozyme Pharma Announces Updates on Global Development Strategy of INZ-701 for the Treatment of ENPP1 Deficiency
Inozyme Pharma, Inc. today announced a regulatory update for its global development strategy of INZ-701 for the treatment of ENPP1 Deficiency following recent meetings with the United States (U.S.) Food and Drug Administration (FDA) and the Paediatric Committee (PDCO) of the European Medicines Agency (EMA).
July 26, 2023
·
11 min read
Business
Agenus to Provide Second Quarter 2023 Financial Report and Corporate Update
Immuno-oncology leader, Agenus (Nasdaq: AGEN), today announced the Company will release its second quarter 2023 financial results via press release before the market opens on Tuesday, August 8, 2023.
July 26, 2023
·
1 min read
Genetown
Oculis Announces to Present at Upcoming August Investor Conferences
Oculis Holding AG today announced that it will participate at the following upcoming investor conferences.
July 26, 2023
·
2 min read
Business
Teknova to Report Second Quarter 2023 Financial Results on August 10, 2023
Alpha Teknova, Inc. today announced that the Company will report its financial results for the second quarter ended June 30, 2023, on Thursday, August 10, 2023, following the close of market.
July 26, 2023
·
1 min read
Drug Development
Ocuphire to Present at American Society of Retina Specialists Annual Meeting and OIS Retina Innovation Summit
Ocuphire Pharma, Inc. today announced that results from the ZETA-1 Phase 2 trial evaluating APX3330 in diabetic retinopathy will be presented at the American Society of Retinal Specialists (ASRS) annual scientific meeting to take place in Seattle, Washington, July 28 to August 1.
July 26, 2023
·
6 min read
Pharm Country
Latest Research Evaluating Clinical Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the European Society of Cardiology (ESC) Congress
Amarin Corporation plc (NASDAQ:AMRN) today announced the acceptance of funded research for presentation at the European Society of Cardiology (ESC) Congress, both onsite and online in Amsterdam, August 25-28, 2023.
July 26, 2023
·
11 min read
Drug Development
PharmAbcine Announces First Patient Dosed in the Phase I Clinical Trial of Its Novel TIE2 Agonistic Antibody in nAMD
PharmAbcine Inc. announced today that the first patient has been dosed in the Phase I clinical trial of PMC-403, the Company’s novel TIE2 agonistic antibody, in nAMD (neovascular age-related macular degeneration).
July 26, 2023
·
4 min read
Genetown
Nexo Therapeutics Launches With $60 Million Series A Financing
Nexo Therapeutics today emerged from stealth with a $60 million Series A financing.
July 26, 2023
·
8 min read
Previous
4 of 16
Next